Inhibitory and excitatory integration with a quantum dot laser neuron
Optics Letters · 2023
DOI: 10.1364/ol.475805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Letters, 2023. Verfasst von M Dillane und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Quantum Dots. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Irish Research eLibrary.
Abstract (Originalsprache)
Neuromorphic computing has garnered a lot of attention in recent years. Excitable photonic systems in particular demonstrate great potential for ultrafast, controllable spike processing. Optically injected quantum dot lasers display several distinct excitable regimes. We demonstrate here that optically injected dual-state quantum dot lasers can display the classic leaky integrate-and-fire mechanism where the integration of several sub-threshold perturbations can yield an effective supra-threshold perturbation. Intriguingly, a contrasting integrate-and-inhibit mechanism is demonstrated in this work where the integration of two supra-threshold perturbations yields an effective sub-threshold perturbation similar to the pre-pulse inhibition mechanism of biological neurons. This is the first such mechanism in neuromorphic photonics to the best of our knowledge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Förderung
- Russian Science Foundation
- Irish Research eLibrary
Zitieren
APA
Dillane, M., Viktorov, E. A., & Kelleher, B. (2023). Inhibitory and excitatory integration with a quantum dot laser neuron. Optics Letters. https://doi.org/10.1364/ol.475805
Vancouver
Dillane M, Viktorov EA, Kelleher B. Inhibitory and excitatory integration with a quantum dot laser neuron. Optics Letters. 2023. doi:10.1364/ol.475805
BibTeX
@article{Dillane2023,
author = {Dillane, M and Viktorov, E A and Kelleher, B},
title = {Inhibitory and excitatory integration with a quantum dot laser neuron},
journal = {Optics Letters},
year = {2023},
doi = {10.1364/ol.475805}
}
EUVIMED